Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00306475
Show Display Options
Rank Status Study
1 Completed Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: divalproex sodium ER;   Drug: placebo

Study has passed its completion date and status has not been verified in more than two years.